EGAPP Working Group / Novo Nordisk Inc. / Practice Centers / Merck & Co. Inc. / adFrom 1Merck & Company Inc. / Predicting / McKing Consulting Corp. / Case / EGAPP Stakeholders Group / /
Country
United States / /
Currency
pence / / /
Event
Business Partnership / /
Facility
Clinical laboratory / American College of Medical Genetics / Buford Highway / National Institute of Standards / University of Washington / Brown University / Laboratory Medicine / Blue Shield Association Technology Evaluation Center / /
IndustryTerm
explicit search strategies / genomic applications / final product / gene products / clinical tool / healthcare providers / Test applications / genetic testing applications / clinical applications / genetic and genomic technologies / carrier tests / carrier testing / quantitative algorithm / genetic test applications / genomic technology / patient management / possible chain / web postings / /
MedicalCondition
rare single gene disorders / future disorder / disorder / classic / early onset cystic fibrosis / specific and well-defined disease / cancer / diabetes / atrial fibrillation / phenotype/clinical disorder / Lynch syndrome / nonpsychotic depression / severe neutropenia / medical disorder / hereditary hemochromatosis / specific disorder / clinically defined disorder / colorectal cancer / higher disorder / heart disease / cystic fibrosis / MS / diagnostic odyssey Disease / breast cancers / disease / future disorders / common complex disorders / heritable breast cancer / cardiogenic stroke / genetic disorders / /
Organization
2National office of Public Health Genomics / National Institute of Standards and Quality / AHRQ EPC / US Preventive Services Task Force / Advisory Committee on Genetics / Health / and Society10 / the American College / University of Washington / Seattle / Warren Alpert Medical School / 5Colorado Department of Public Health and Environment / Food and Drug Administration / National office of Public Health Genomics / Brown University / EWG Topics Subcommittee / 4Blue Cross/Blue Shield Association Technology Evaluation Center / Risk assessment/susceptibility Association / assessment/susceptibility Association / Centers for Disease Control and Prevention / Centre for Evidence Based Medicine / 47 / CDC’s NOPHG / Advisory Committee / EWG Methods Subcommittee / Agency for Healthcare Research and Quality / /
Person
James E. Haddow / Michael P. Douglas / Steven M. Teutsch / Alfred O. Berg / Linda A. Bradley / W. David Dotson / Ned Calonge / Margaret Piper / Glenn E. Palomaki / /
Position
Secretary / pilot project / representative / contractor for expert peer-review / specimens representative / Governor / Chair / /
Product
herceptin / /
ProvinceOrState
Washington / Rhode Island / Georgia / Colorado / Illinois / Pennsylvania / /
ARTICLE The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group Steven M. Teutsch, MD, MPH1, Linda A. Bradley, PhD2, Glenn E. Palomaki, BS3,